Previous 10 | Next 10 |
REDWOOD CITY, Calif. , Jan. 7, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that, in collaboration with physicians around the world, it has delivered more than 1 million Oncotype DX ® tests to cancer patients worldwide since it made its f...
Genomic Health ( GHDX ) is a top provider of genomic-based diagnostic tests that help optimize cancer care, including addressing the overtreatment of the disease, one of the greatest issues in healthcare today. Genomic Health offers its tissue-based invasive breast, prostate, colon, and DCIS O...
REDWOOD CITY, Calif. , Dec. 10, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced results from multiple Oncotype DX Breast Recurrence Score ® (RS) presentations at the 2018 San Antonio Breast Cancer Symposium ® (SABCS), reinforcing the value of the Oncot...
REDWOOD CITY, Calif. and MECHELEN, Belgium , Dec. 3, 2018 /PRNewswire/ -- Genomic Health , Inc. (NASDAQ: GHDX), the world's leading provider of genomic-based diagnostic tests and Biocartis Group NV, an innovative molecular diagnostics company (Euronext Brussels: BCART), today ...
Simplicity is the ultimate sophistication. The more simple and straightforward the rationale for buying a stock, the better the chances of success. At the end of the day, investing is all about answering two main questions: what to buy and when to buy it. This article is introducing a quanti...
Genomic Health ( GHDX +23.5% ) is up on modestly higher volume after releasing better-than-expected results after the close yesterday. Highlights: More news on: Genomic Health, Inc., Read more ...
Genomic Health, Inc. (GHDX) Q3 2018 Results Conference Call November 06, 2018 04:30 PM ET Executives Emily Faucette - Vice President of Corporate Communications and Investor Relations Kim Popovits - Chairman of the Board, Chief Executive Officer and President Brad Cole - Chief Fi...
Genomic Health (NASDAQ: GHDX ): Q3 GAAP EPS of $0.32 beats by $0.27 . More news on: Genomic Health, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
REDWOOD CITY, Calif. , Nov. 6, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter ended September 30, 2018 . "We continue to deliver record results in 2018, including 23 percent revenue growth and $...
ACAD , AAXN , AIZ , APEI , ASH , BEL , BOLD , BWXT , CHUY , COHR , CPE , CSLT , CUTR , CWH , DAR , DATA , DIOD , DK , DOOR , DPLO , DVN , DXC , DXCM , EGN , ENLC , ENLK , ENPH , ETSY , EVH , EVRI , FANG , FIVN , FTK , FTR , G , GDDY , GHDX , GLUU , HAL...
News, Short Squeeze, Breakout and More Instantly...
Genomic Health Inc. Company Name:
GHDX Stock Symbol:
NASDAQ Market:
Broadly, genetics is the study of genes, their variations and hereditary characteristics. As Live Science describes it , genetics involves looking at how traits are passed on through generations. So what is genetics investing? When it comes to genetics investing, companies in this niche li...
Combined company joins two leading brands in cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growth MADISON, Wisconsin , Nov. 8, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed its...
REDWOOD CITY, Calif. , Nov. 7, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) announced that its stockholders voted to approve the company's proposed combination with Exact Sciences Corp (NASDAQ: EXAS) at a special meeting held earlier today. As previously announced...